About this trial
This study aims to develop a non-invasive and rapid diagnostic technology for acute upper gastrointestinal bleeding (AUGIB) by analyzing volatile organic compounds (VOCs) in exhaled breath. Clinically confirmed patients will be divided into three groups (no bleeding, minor bleeding, major bleeding) based on endoscopic findings. VOC profiles will be analyzed to construct a predictive model, validated for sensitivity and specificity (both targets ≥0.7). This approach addresses the limitations of endoscopy in emergency or resource-limited settings, improving diagnostic efficiency and reducing mortality.
Eligibility criteria
Qualifiers
Age ≥18 years;
Clinical suspicion of AUGIB (e.g., hematemesis, melena);
Fasting ≥4 hours;
Signed informed consent.
Disqualifiers
Severe pulmonary dysfunction or recent lung infection (within 1 week);
Cardiac/renal failure or disseminated intravascular coagulation;
Contraindications to endoscopy;
High-risk conditions (e.g., massive ascites);
Trial design
Treatments tested in this trial
- Gastroscopy
- Gas Chromatography - Mass Spectrometry